Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
paroxetine hydrochloride
|
| gptkbp:ATCCode |
N06AB05
|
| gptkbp:contraindication |
concomitant use with MAO inhibitors
|
| gptkbp:countryOfOrigin |
gptkb:India
|
| gptkbp:form |
gptkb:tablet
extended-release tablet |
| https://www.w3.org/2000/01/rdf-schema#label |
Lavida XR
|
| gptkbp:indication |
gptkb:generalized_anxiety_disorder
gptkb:panic_disorder gptkb:post-traumatic_stress_disorder gptkb:social_anxiety_disorder gptkb:major_depressive_disorder pre-menstrual dysphoric disorder |
| gptkbp:manufacturer |
gptkb:Torrent_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
selective serotonin reuptake inhibitor
|
| gptkbp:pregnancyCategory |
D (India)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
drowsiness dry mouth sexual dysfunction |
| gptkbp:bfsParent |
gptkb:Volkswagen_Lavida
|
| gptkbp:bfsLayer |
7
|